🔎 Trials Near Me

Hem › Neuroblastom › District of Columbia › Washington

Kliniska studier för Neuroblastom i Washington, DC

11 studier för Neuroblastom söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

RekryterarFas 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 120 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06041516

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

RekryterarObservationsstudieFriska volontärer välkomna
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
4 Weeks · Alla kön · Uppdaterad 2 okt. 2026 · NCT01109394

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RekryterarFas 3
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi bort
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

RekryterarFas 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 3 till 35 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

RekryterarObservationsstudie
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 4 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RekryterarFas 3
  • Children's National Medical Center, Washington D.C.
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekryterarFas 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

RekryterarFas 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Ålder 1 till 23 · Alla kön · Uppdaterad 13 aug. 2026 · NCT07172958

SPEARHEAD-3 Pediatric Study

RekryterarFas 1/2
  • National Institutes of Health, Bethesda · 7 mi bort
Ålder 2 till 21 · Alla kön · Uppdaterad 11 aug. 2026 · NCT05642455

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RekryterarFas 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alla kön · Uppdaterad 19 maj 2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RekryterarFas 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Alla kön · Uppdaterad 12 aug. 2025 · NCT05135975

Neuroblastom-studier i andra städer

Andra studier i Washington

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.